Research Shows That Telehealth Has the Power to Meet the Needs of Vulnerable Communities
Telehealth resources have been present in the United States for several decades. Traditionally, clinicians used telehealth to help rural populations with limited access to care. However, telehealth innovations expand beyond home care coordination. We can use technology to reach even the most remote and vulnerable patients.
- Read more about Research Shows That Telehealth Has the Power to Meet the Needs of Vulnerable Communities
- Add new comment
Nurse Legislator’s Healthcare Affordability Act Included in Patient Protection and Affordable Care Enhancement Act
Legislation aimed at reducing health care insurance premiums, introduced by U.S. Representative Lauren A. Underwood (D-IL), is included as part of the Patient Protection and Affordable Care Enhancement Act.
- Read more about Nurse Legislator’s Healthcare Affordability Act Included in Patient Protection and Affordable Care Enhancement Act
- Add new comment
Lohxa, LLC, Recalls Chlorhexidine Gluconate Oral Rinse Because of Microbial Contamination
Lohxa, LLC, issued a voluntary recall of five lots of its alcohol-free chlorhexidine gluconate oral rinse USP 0.12% because of a risk that the product may be contaminated with the bacteria Burkholderia lata. The U.S Food and Drug Administration announced the recall on November 9, 2020.
- Read more about Lohxa, LLC, Recalls Chlorhexidine Gluconate Oral Rinse Because of Microbial Contamination
- Add new comment
Nurses Can Access $85.3 Million of HHS Workforce Funding Awards
Up to $85.3 million of the U.S. Department of Health and Human Services’ (HHS’s) $107.2 million in funding awards is earmarked for nurses. The agency bestowed the awards in June 2020 to 310 recipients across 45 states and U.S. territories to increase the healthcare workforce in rural and underserved communities.
Manage Cancer Treatment-Related Skin Toxicities With ONS Guidelines™
From chemotherapy to immunotherapy, many of today’s cancer treatments are associated with skin toxicities. Left unmanaged, they can affect patients’ activities of daily living, self-image, and overall quality of life and may lead to treatment disruptions, delays, or even discontinuation.
Cures 2.0 Act Would Expand on the Successes of 21st Century Cures Legislation
Building on the success of the 21st Century Cures Act passed in 2016, U.S. Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) have begun work on the follow-up Cures 2.0 Act, intended to “safely and efficiently modernize the delivery of health care in the wake of the coronavirus pandemic,” the representatives said in a press release.
- Read more about Cures 2.0 Act Would Expand on the Successes of 21st Century Cures Legislation
- Add new comment
ONS Board Closely Monitors Financials to Support Member Programs
At the ONS Board of Directors meeting on September 24–25, 2020, Board members reviewed both the organization’s year-to-date financial and investment performance as part of their stewardship responsibility. They also made plans for a data dashboard to drive decisions and discussed training options for expanding oncology nurses’ voices in the media. Highlights from those discussions follow, and the full minutes from the meeting are available at ons.org/board-minutes.
Resource Helps Explain the Potential Dangers of E-Cigarettes to Providers and Patients
E-cigarettes are dangerous and their risks outweigh any potential smoking-cessation benefits, the U.S. Government Accountability Office explained in a new two-page resource that analyzes the science and technology behind the devices.
- Read more about Resource Helps Explain the Potential Dangers of E-Cigarettes to Providers and Patients
- Add new comment
The Case of the Terrible Taste
Tanya is a 46-year-old woman with leukemia. She recently finished induction therapy, and her oncologist told her she is ready to receive a hematopoietic stem cell transplant. You speak with Tanya about what to expect in the upcoming weeks before her transplant, but she interrupts you: “Nothing tastes good anymore. I am so scared because I thought I completed chemotherapy. The doctor just told me I have to get more before my transplant. Every time I get chemotherapy, I lose my appetite.”
Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship
Lung cancer is the leading cause of cancer death in the United States, accounting for about one quarter of cancer deaths, and more than a quarter of million lung cancer diagnoses are projected in the United States for 2020. Lung cancer has various types, pathologies, and histologies, each with its own prognosis and treatment plan. Non-small cell lung cancer consists of about 80%–85% of lung cancer diagnoses.